| abstract |
Novel nucleic acid sequences named and set forth in FIG. 1 and FIG. 2 , and variants thereof, are described wherein a nucleic acid sequence of the invention exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers such as those listed in Table I. Consequently, expression of a nucleic acid sequence of FIG. 1 or FIG. 2 provides diagnostic, prognostic, prophylactic and/or therapeutic targets for cancer. |